LOS ANGELES, CA--(Marketwire - November 12, 2008) - Clearant, Inc. (OTCBB: CLRA), owner of the Clearant Process® designed to substantially reduce all types of pathogens in biological products including HIV, today announced that preliminary revenues for the nine months ending September 30, 2008 increased 88% to $1.43 million compared to $0.76 million for the nine months ending September 30, 2007.
